Johnathan S. Dordick

Howard P. Isermann Professor
Vice President for Research
Contact Information
Office: CBIS 2215
Phone: 518-276-2899
E-mail: dordick@rpi.edu
Website: http://enzymes.che.rpi.edu/
Education
Ph.D. Biochemical Engineering, Massachusetts Institute of Technology, 1986
M.S. Biochemical Engineering, Massachusetts Institute of Technology, 1983
B.A. Biochemistry and Chemistry, Brandeis University, 1980
Biography
Jonathan S. Dordick is the Vice President for Research and the Howard P. Isermann Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute. Prof. Dordick received his B.A. degree in Biochemistry and Chemistry from Brandeis University and his Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology. He has held chemical engineering faculty appointments at the University of Iowa (1987-1998), where he also served as the Associate Director of the Center for Biocatalysis and Bioprocessing, and Rensselaer Polytechnic Institute (1998-present) where he also holds joint appointments in the departments of Biomedical Engineering, Materials Science and Engineering, and Biology. Prof. Dordick’s research group includes chemical engineers, bioengineers, materials scientists, biologists, chemists and microbiologists all focused on gaining a quantitative understanding of biological principles and applying them to advance bioengineering, nanobiotechnology, drug discovery, and biomanufacturing. He has received numerous awards, including the 2007 Marvin J. Johnson Award and the 2007 Elmer Gaden Award both of the American Chemical Society, the 2003 International Enzyme Engineering Award, the 1998 Iowa Section Award of the American Chemical Society, and an NSF Presidential Young Investigator Award in 1989. He was elected as a Fellow of the American Chemical Society in 2010, a Fellow of the American Association for the Advancement of Science in 2004, and a Fellow of the American Institute of Medical and Biological Engineers in 1996. He presently serves on the Scientific Advisory Boards for several biotechnology companies and venture capital firms, and has cofounded a number of companies, including EnzyMed (now part of Albany Molecular Research, Inc.), Solidus Biosciences, and The Paper Battery Company. Dr. Dordick has published over 330 papers and is an inventor/co-inventor on nearly 40 patents and patent applications.
 
Research Interests
Biocatalysis, Molecular Bioprocessing, Drug Discovery, Biomolecular Surfaces
 
Current Research
The Dordick group includes chemical engineers, bioengineers, materials scientists, biologists, chemists and microbiologists all focused on gaining a quantitative understanding of biological principles and applying them to advance bioengineering, materials science, and drug discovery. Specific areas of current research include enzyme structure and function at biological-material interfaces and in nonaqueous environments, high-throughput biocatalysis in drug and functional materials discovery, biochip development for identification of drug candidate toxicity and biologically-inspired nanocomposites for 2D and 3D functional architectures.